Cystic fibrosis and lipoxins

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 3-4, 2005, Pages 263-270

  Karp, Christopher L ^a,c   Flick, Leah M ^a   Yang, Rong ^d   Uddin, Jasim ^d   Petasis, Nicos A ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPOXIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AIRWAY; CYSTIC FIBROSIS; HUMAN; INFLAMMATION; LINKAGE ANALYSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 24344506254     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.05.015     Document Type: Article

References (84)

1. T.F. Boat, M.J. Welsh, and A.L. Beaudet The metabolic basis of inherited disease C.R. Scriver A.L. Beaudet W.S. Sly D. Valle Cystic Fibrosis 1989 McGraw-Hill New York 2649
2. J.E. Mickle, and G.R. Cutting Clinical implications of cystic fibrosis transmembrane conductance regulator mutations Clin. Chest Med. 19 1998 443
3. C. Robinson, and T.F. Scanlin A.P. Fishman J.A. Elias J.A. Fishman M.A. Grippi L.R. Kaiser R.M. Senior Cystic Fibrosis, in Fishman's Pulmonary Diseases and Disorders 1998 McGraw-Hill New York 803
4. F. Ratjen, and G. Döring Cystic fibrosis Lancet 361 2003 681 689
5. J.M. Rommens, M.C. Iannuzzi, B. Kerem, M.L. Drumm, G. Melmer, M. Dean, R. Rozmahel, J.L. Cole, D. Kennedy, and N. Hidaka Identification of the cystic fibrosis gene: chromosome walking and jumping Science 245 1989 1059
6. J.M. Pilewski, and R.A. Frizzell Role of CFTR in airway disease Physiol. Rev. 79 1999 S215
7. A. Mehta CFTR: more than just a chloride channel Pediatr. Pulmonol. 39 2005 292 298
8. N. Kalin, A. Claass, M. Sommer, E. Puchelle, and B. Tummler ΔF508 CFTR protein expression in tissues from patients with cystic fibrosis J. Clin. Invest. 103 1999 1379 1389
9. E.M. Schwiebert, D.J. Benos, M.E. Egan, M.J. Stutts, and W.B. Guggino CFTR is a conductance regulator as well as a chloride channel Physiol. Rev. 79 1999 S145
10. N.A. Bradbury Intracellular CFTR: localization and function Physiol. Rev. 79 1999 S175
11. T.J. Kelley, and H.L. Elmer In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium J. Clin. Invest. 106 2000 403
12. O. Tabary, S. Escotte, J.P. Couetil, D. Hubert, D. Dusser, E. Puchelle, and J. Jacquot High susceptibility for cystic fibrosis human airway gland cells to produce IL-8 through the I kappa B kinase alpha pathway in response to extracellular NaCl content J. Immunol. 164 2000 3377
13. R. Tirouvanziam, S.D. Bentzmann, C. Hubeau, J. Hinnrasky, J. Jacquot, B. Peault, and E. Puchelle Inflammation and infection in naive human cystic fibrosis airway grafts Am. J. Respir. Cell Mol. Biol. 23 2000 121
14. C. Andersson, and G.M. Roomans Activation of deltaF508 CFTR in a cystic fibrosis respiratory epithelial cell line by 4-phenylbutyrate, genistein and CPX Eur. Respir. J. 15 2000 937
15. J. Bargon, B.C. Trapnell, K. Yoshimura, W. Dalemans, A. Pavirani, J.P. Lecocq, and R.G. Crystal Expression of the cystic fibrosis transmembrane conductance regulator gene can be regulated by protein kinase C J. Biol. Chem. 267 1992 16056
16. F. Besancon, G. Przewlocki, I. Baro, A.S. Hongre, D. Escande, and A. Edelman Interferon-gamma downregulates CFTR gene expression in epithelial cells Am. J. Physiol. 267 1994 C1398
17. N.B. Sweezey, F. Ghibu, and S. Gagnon Sex hormones regulate CFTR in developing fetal rat lung epithelial cells Am. J. Physiol. 272 1997 L844
18. Y. Xu, J.C. Clark, B.J. Aronow, C.R. Dey, C. Liu, J.L. Wooldridge, and J.A. Whitsett Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency J. Biol. Chem. 278 2003 7674
19. J.D. Groman, M.E. Meyer, R.W. Wilmott, P.L. Zeitlin, and G.R. Cutting Variant cystic fibrosis phenotypes in the absence of CFTR mutations N. Engl. J. Med. 347 2002 401
20. M. Mall, B.R. Grubb, J.R. Harkema, W.K. O'Neal, and R.C. Boucher Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice Nat. Med. 10 2004 487
21. R. Bals, D.J. Weiner, and J.M. Wilson The innate immune system in cystic fibrosis lung disease J. Clin. Invest. 103 1999 303
22. S. Jayaraman, N.S. Joo, B. Reitz, J.J. Wine, and A.S. Verkman Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity Proc. Natl. Acad. Sci. USA 98 2001 8119
23. H. Matsui, B.R. Grubb, R. Tarran, S.H. Randell, J.T. Gatzy, C.W. Davis, and R.C. Boucher Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease Cell 95 1998 1005
24. G.B. Pier, M. Grout, T.S. Zaidi, J.C. Olsen, L.G. Johnson, J.R. Yankaskas, and J.B. Goldberg Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections Science 271 1996 64
25. L. Saiman, and A. Prince Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells J. Clin. Invest. 92 1993 1875
26. J.J. Smith, S.M. Travis, E.P. Greenberg, and M.J. Welsh Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid Cell 85 1996 229
27. R. Tarran, B.R. Grubb, D. Parsons, M. Picher, A.J. Hirsh, C.W. Davis, and R.C. Boucher The CF salt controversy: in vivo observations and therapeutic approaches Mol. Cell 8 2001 149
28. J.J. Wine The genesis of cystic fibrosis lung disease J. Clin. Invest. 103 1999 309
29. T.L. Bonfield, J.R. Panuska, M.W. Konstan, K.A. Hilliard, J.B. Hilliard, H. Ghnaim, and M. Berger Inflammatory cytokines in cystic fibrosis lungs Am. J. Respir. Crit. Care Med. 152 1995 2111
30. T.P. Dean, Y. Dai, J.K. Shute, M.K. Church, and J.O. Warner Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis Pediatr. Res. 34 1993 159
31. T.L. Noah, H.R. Black, P.W. Cheng, R.E. Wood, and M.W. Leigh Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis J. Infect. Dis. 175 1997 638
32. E. Osika, J.M. Cavaillon, K. Chadelat, M. Boule, C. Fitting, G. Tournier, and A. Clement Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease Eur. Respir. J. 14 1999 339
33. A. Schuster, A. Haarmann, and V. Wahn Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis Eur. Arch. Otorhinolaryngol. Suppl 1995 1
34. C. Wojnarowski, T. Frischer, E. Hofbauer, C. Grabner, W. Mosgoeller, I. Eichler, and R. Ziesche Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation Eur. Respir. J. 14 1999 1136
35. K. Balough, M. McCubbin, M. Weinberger, W. Smits, R. Ahrens, and R. Fick The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis Pediatr. Pulmonol. 20 1995 63
36. T.Z. Khan, J.S. Wagener, T. Bost, J. Martinez, F.J. Accurso, and D.W. Riches Early pulmonary inflammation in infants with cystic fibrosis Am. J. Respir. Crit. Care Med. 151 1995 1075
37. M.S. Muhlebach, and T.L. Noah Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis Am. J. Respir. Crit. Care Med. 165 2002 911 915
38. M.S. Muhlebach, P.W. Stewart, M.W. Leigh, and T.L. Noah Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients Am. J. Respir. Crit. Care Med. 160 1999 186 191
39. S. Baconnais, R. Tirouvanziam, J.M. Zahm, S.D. Bentzmann, B. Peault, G. Balossier, and E. Puchelle Ion composition and rheology of airway liquid from cystic fibrosis fetal tracheal xenografts Am. J. Respir. Cell Mol. Biol. 20 1999 605
40. Cheng K, Ashby D, Smyth R. Oral steroids for cystic fibrosis. Cochrane Database Systems Review, vol. 2, 2000.
41. M.W. Konstan, K.M. Vargo, and P.B. Davis Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis Am. Rev. Respir. Dis. 141 1990 186
42. U.E. Hopken, B. Lu, N.P. Gerard, and C. Gerard The C5a chemoattractant receptor mediates mucosal defence to infection Nature 383 1996 86
43. H.A. Wyatt, A.P. Sampson, I.M. Balfour-Lynn, and J.F. Price Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children Respir. Med. 94 2000 106
44. M.B. McChesney, and M.B. Oldstone Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression Annu. Rev. Immunol. 5 1987 279
45. N.G. McElvaney, R.C. Hubbard, P. Birrer, M.S. Chernick, D.B. Caplan, M.M. Frank, and R.G. Crystal Aerosol alpha 1-antitrypsin treatment for cystic fibrosis Lancet 337 1991 392
46. H.F. Rosenberg, and J.I. Gallin Inflammation W.E. Paul Fundamental Immunology Fourth ed 1999 Lippincott-Raven Philadelphia 1051
47. C. Hubeau, M. Lorenzato, J.P. Couetil, D. Hubert, D. Dusser, E. Puchelle, and D. Gaillard Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa Clin. Exp. Immunol. 124 2001 69
48. C.N. Serhan Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53 1997 107 137
49. C.N. Serhan, B.D. Levy, C.B. Clish, K. Gronert, and N. Chiang Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity Ernst Schering Res. Found. Workshop 31 2000 143 185
50. I.M. Fierro, and C.N. Serhan Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins Braz. J. Med. Biol. Res. 34 2001 555 566
51. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat. Immunol. 2 2001 612 619
52. C.N. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution Prostag. Other Lipid Mediat. 68-69 2002 433 455
53. T. Lawrence, D.A. Willoughby, and D.W. Gilroy Anti-inflammatory lipid mediators and insights into the resolution of inflammation Nat. Rev. Immunol. 2 2002 787 795
54. N.E. Kieran, P. Maderna, and C. Godson Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease Kidney Int. 65 2004 1145 1154
55. C. Bonnans, P. Chanez, and C. Chavis Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy 59 2004 1027 1041
56. J. Clária, and C.N. Serhan Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions Proc. Natl. Acad. Sci. USA 92 1995 9475 9479
57. C.B. Clish, J.A. O'Brien, K. Gronert, G.L. Stahl, N.A. Petasis, and C.N. Serhan Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo Proc. Natl. Acad. Sci. USA 96 1999 8247 8252
58. C.N. Serhan, J.F. Maddox, N.A. Petasis, I. Akritopoulou-Zanze, A. Papayianni, H.R. Brady, S.P. Colgan, and J.L. Madara Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils Biochemistry 34 1995 14609 14615
59. 4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors J. Exp. Med. 185 1997 1693 1704
60. A.T. Gewirtz, B. McCormick, A.S. Neish, N.A. Petasis, K. Gronert, C.N. Serhan, and J.L. Madara Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs J. Clin. Invest. 101 1998 1860 1869
61. K. Gronert, A. Gewirtz, J.L. Madara, and C.N. Serhan Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon γ and inhibits tumor necrosis factor α-induced IL-8 release J. Exp. Med. 187 1998 1285 1294
62. 4 inhibit tumor necrosis factor α-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis J. Exp. Med. 189 1999 1923 1929
63. 4 antagonize TNF-α-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-α-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo J. Immunol. 167 2001 2772 2780
64. S. Mitchell, G. Thomas, K. Harvey, D. Cottell, K. Reville, G. Bernasconi, N.A. Petasis, L. Erwig, A.J. Rees, J. Savill, H.R. Brady, and C. Godson Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: Stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo J. Am. Nephrol. 13 2002 2497 2507
65. B.D. Levy, and C.N. Serhan Exploring new approaches to the treatment of asthma: Potential roles for lipoxins and aspirin-triggered lipid mediators Drugs Today 39 2003 373 384
66. C.N. Serhan, A. Jain, S. Marleau, C. Clish, A. Kantarci, B. Behbehani, S.P. Colgan, G.L. Stahl, A. Merched, N.A. Petasis, L. Chan, and T.E. Van Dyke Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators J. Immunol. 171 2003 6856 6865
67. C.L. Karp, L.M. Flick, K.W. Park, S. Softic, T.M. Greer, R. Keledjian, R. Yang, J. Uddin, W.B. Guggino, S.F. Atabani, Y. Belkaid, Y. Xu, J.A. Whitsett, F.J. Accurso, M. Wills-Karp, and N.A. Petasis Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway Nat. Immunol. 5 2004 388 392
68. D. Takai, T. Nagase, and T. Shimizu New therapeutic key for cystic fibrosis: a role for lipoxins Nat. Immunol. 5 2004 357 358
69. P.K. Stotland, D. Radzioch, and M.M. Stevenson Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis Pediatr. Pulmonol. 30 2000 413
70. A.M. van Heeckeren, and M.D. Schluchter Murine models of chronic Pseudomonas aeruginosa lung infection Lab. Animal 36 2002 291
71. J.R. Starke, M.S. Edwards, C. Langston, and C.J. Baker A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia Pediatr. Res. 22 1987 698
72. J.W. Costerton Cystic fibrosis pathogenesis and the role of biofilms in persistent infection Trends Microbiol. 9 2001 50
73. M.W. Konstan, R.W. Walenga, K.A. Hilliard, and J.B. Hilliard Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis Am. Rev. Respir. Dis. 148 1993 896
74. P. Kuo, N. Huang, and D. Bassett The fatty acid composition of the serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancreas J. Pediatr. 60 1962 394
75. M. Roulet, P. Frascarolo, I. Rappaz, and M. Pilet Essential fatty acid deficiency in well nourished young cystic fibrosis patients Eur. J. Pediatr. 156 1997 952
76. S.D. Freedman, M.H. Katz, E.M. Parker, M. Laposata, M.Y. Urman, and J.G. Alvarez A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr-/- mice Proc. Natl. Acad. Sci. USA 96 1999 13995 14000
77. S.D. Freedman, P.G. Blanco, M.M. Zaman, J.C. Shea, M. Ollero, I.K. Hopper, D.A. Weed, A. Gelrud, M.M. Regan, M. Laposata, J.G. Alvarez, and B.P. O'Sullivan Association of cystic fibrosis with abnormalities in fatty acid metabolism N. Engl. J. Med. 350 2004 560 569
78. S.D. Freedman, J.C. Shea, P.G. Blanco, and J.G. Alvarez Fatty acids in cystic fibrosis Curr. Opin. Pulm. Med. 6 2000 530 532
79. B. De Vizia, V. Raia, C. Spano, C. Pavlidis, A. Coruzzo, and M. Alessio Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis J. Parenter. Enteral Nutr. 27 2003 52
80. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, G. Mirick, and L. Moussignac R- Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J. Exp. Med. 196 2002 1025 1037
81. C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing J. Exp. Med. 192 2000 1197 1204
82. S. Hong, K. Gronert, P.R. Devchand, L. Moussignac R-, and C.N. Serhan Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation J. Biol. Chem. 278 2003 14677 14687
83. M. Arita, F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N.A. Petasis, and C.N. Serhan Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 J. Exp. Med. 201 2005 713 722
84. R.E. Vance, S. Hong, K. Gronert, C.N. Serhan, and J.J. Mekalanos The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase Proc. Natl. Acad. Sci. USA 101 2004 2135 2139